| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A multicenter phase II trial of etoposide, methylprednisolone, high-dose cytarabine, and oxaliplatin for patients with primary refractory/relapsed aggressive non-Hodgkin’s lymphoma
|
Sym, Sun Jin
|
|
2008
|
64 |
1 |
p. 27-33
|
artikel
|
| 2 |
Anticancer activities of sesquiterpene lactones from Cyathocline purpurea in vitro
|
Ma, Guoyi
|
|
2008
|
64 |
1 |
p. 143-152
|
artikel
|
| 3 |
A phase II trial of weekly chemotherapy with paclitaxel plus gemcitabine as a first-line treatment in advanced non-small-cell lung cancer
|
Mori, Kiyoshi
|
|
2008
|
64 |
1 |
p. 73-78
|
artikel
|
| 4 |
Carboplatin dosing in overweight and obese patients with normal renal function, does weight matter?
|
Ekhart, Corine
|
|
2008
|
64 |
1 |
p. 115-122
|
artikel
|
| 5 |
Concurrent radiotherapy: fotemustine combination for newly diagnosed malignant glioma patients, a phase II study
|
Beauchesne, Patrick D.
|
|
2009
|
64 |
1 |
p. 171-175
|
artikel
|
| 6 |
Do anthocyanins and anthocyanidins, cancer chemopreventive pigments in the diet, merit development as potential drugs?
|
Thomasset, Sarah
|
|
2009
|
64 |
1 |
p. 201-211
|
artikel
|
| 7 |
Dose-escalation study of fixed-dose rate gemcitabine combined with capecitabine in advanced solid malignancies
|
Attia, Steven
|
|
2008
|
64 |
1 |
p. 45-51
|
artikel
|
| 8 |
Dose finding study of erlotinib combined to capecitabine and irinotecan in pretreated advanced colorectal cancer patients
|
Bajetta, Emilio
|
|
2008
|
64 |
1 |
p. 67-72
|
artikel
|
| 9 |
Enhanced absorption and tissue distribution of paclitaxel following oral administration of DHP 107, a novel mucoadhesive lipid dosage form
|
Shin, Beom Soo
|
|
2008
|
64 |
1 |
p. 87-94
|
artikel
|
| 10 |
Enhanced absorption and tissue distribution of paclitaxel following oral administration of DHP 107, a novel mucoadhesive lipid dosage form
|
Shin, Beom Soo
|
|
2009
|
64 |
1 |
p. 95-96
|
artikel
|
| 11 |
Evaluation of mRNA by Q-RTPCR and protein expression by AQUA of the M2 subunit of ribonucleotide reductase (RRM2) in human tumors
|
Kolesar, Jill
|
|
2008
|
64 |
1 |
p. 79-86
|
artikel
|
| 12 |
Influence of the etiology of liver cirrhosis on the response to combined intra-arterial chemotherapy in patients with advanced hepatocellular carcinoma
|
Kanayama, Masahiro
|
|
2008
|
64 |
1 |
p. 109-114
|
artikel
|
| 13 |
Intrathoracic injection of paclitaxel for a patient with stage IV serous ovarian cancer: a case report
|
Mitamura, Takashi
|
|
2009
|
64 |
1 |
p. 169-170
|
artikel
|
| 14 |
Irinotecan-induced mucositis is associated with changes in intestinal mucins
|
Stringer, Andrea M.
|
|
2008
|
64 |
1 |
p. 123-132
|
artikel
|
| 15 |
Matrix metalloproteinases: key regulators in the pathogenesis of chemotherapy-induced mucositis?
|
Al-Dasooqi, Noor
|
|
2009
|
64 |
1 |
p. 1-9
|
artikel
|
| 16 |
MDR1 (ABCB1) G1199A (Ser400Asn) polymorphism alters transepithelial permeability and sensitivity to anticancer agents
|
Woodahl, Erica L.
|
|
2009
|
64 |
1 |
p. 183-188
|
artikel
|
| 17 |
Nuclear receptor mediated induction of cytochrome P450 3A4 by anticancer drugs: a key role for the pregnane X receptor
|
Harmsen, S.
|
|
2008
|
64 |
1 |
p. 35-43
|
artikel
|
| 18 |
Pharmacokinetics and tissue distribution of Kendine 91, a novel histone deacetylase inhibitor, in mice
|
Otaegui, Dorleta
|
|
2008
|
64 |
1 |
p. 153-159
|
artikel
|
| 19 |
Phase I study of the combination of docetaxel, temozolomide and cisplatin in patients with metastatic melanoma
|
Kim, Kevin B.
|
|
2008
|
64 |
1 |
p. 161-167
|
artikel
|
| 20 |
Population pharmacokinetics meta-analysis of plitidepsin (Aplidin®) in cancer subjects
|
Nalda-Molina, Ricardo
|
|
2008
|
64 |
1 |
p. 97-108
|
artikel
|
| 21 |
Rituximab-based therapy for gemcitabine-induced hemolytic uremic syndrome in a patient with metastatic pancreatic adenocarcinoma: a case report
|
Bharthuar, Anubha
|
|
2008
|
64 |
1 |
p. 177-181
|
artikel
|
| 22 |
Role of copper transporters in resistance to platinating agents
|
Rabik, Cara A.
|
|
2008
|
64 |
1 |
p. 133-142
|
artikel
|
| 23 |
Sequential development of mutant clones in an imatinib resistant chronic myeloid leukaemia patient following sequential treatment with multiple tyrosine kinase inhibitors: an emerging problem?
|
Breccia, Massimo
|
|
2009
|
64 |
1 |
p. 195-197
|
artikel
|
| 24 |
Topoisomerase I involvement in schedule-dependent interaction between 5-fluoro-uracil and irinotecan in the treatment of colorectal cancer
|
Richter, Sara N.
|
|
2009
|
64 |
1 |
p. 199-200
|
artikel
|
| 25 |
To widen the setting of cancer patients who could benefit from metronomic capecitabine
|
Nannini, Margherita
|
|
2009
|
64 |
1 |
p. 189-193
|
artikel
|
| 26 |
Treatment of metastatic renal cell carcinoma
|
Reeves, David J.
|
|
2009
|
64 |
1 |
p. 11-25
|
artikel
|
| 27 |
Voreloxin, formerly SNS-595, has potent activity against a broad panel of cancer cell lines and in vivo tumor models
|
Hoch, Ute
|
|
2008
|
64 |
1 |
p. 53-65
|
artikel
|
Tijdschrift beschrijving